Alder BioPharmaceuticals® to Present Data from Eptinezumab Development Program at 18th Congress of the International Headache Society
September 07, 2017 08:30 ET
|
Alder BioPharmaceuticals, Inc.
BOTHELL, Wash., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today...
Alder BioPharmaceuticals® Announces Second Quarter 2017 Financial and Operating Results
August 08, 2017 16:05 ET
|
Alder BioPharmaceuticals, Inc.
– Positive top-line PROMISE 1 study results further support eptinezumab’s unique clinical profile – – $161.5 million from recent public offering expected to enable continued advancement of...
Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2017 Financial and Operating Results
August 01, 2017 08:00 ET
|
Alder BioPharmaceuticals, Inc.
BOTHELL, Wash., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today...
CoLucid Pharmaceuticals Announces Initiation of Second Phase 3 Pivotal Trial of Lasmiditan in Migraine
May 19, 2016 12:46 ET
|
CoLucid Pharmaceuticals, Inc
First Patient Randomized in SPARTAN StudyTrial Being Conducted Under Special Protocol Assessment Agreement with FDA CAMBRIDGE, Mass., May 19, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals,...
Pernix Therapeutics Overcomes Challenge to Treximet® ‘183 Patent
May 09, 2016 08:00 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that on May 6, 2016, the Patent Trial and...
World’s First Summit Set to Relieve Pain Experienced by Millions
April 12, 2016 10:00 ET
|
National Headache Foundation
CHICAGO, April 12, 2016 (GLOBE NEWSWIRE) -- In a world first, migraine sufferers now have an opportunity to jump the waiting list and get free access to international migraine experts at the...
National Headache Foundation Receives Significant Donations
March 03, 2016 10:00 ET
|
National Headache Foundation
CHICAGO, March 03, 2016 (GLOBE NEWSWIRE) -- Dr. Seymour Diamond, President of the Diamond Fellowship and Educational Foundation, and his family are pleased to announce the Board of Directors has...
CoLucid Pharmaceuticals and IMS Health Publish White Paper to Address Migraine Market Misperceptions
January 05, 2016 07:00 ET
|
CoLucid Pharmaceuticals, Inc
CAMBRIDGE, MA, Jan. 05, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), a Phase 3 clinical-stage biopharmaceutical company that is developing its lead product candidate,...
Groton Chiropractic Center Welcomes Two New Doctors
November 18, 2012 10:00 ET
|
Advanced Back & Neck Care Center
GROTON, Conn., Nov. 18, 2012 (GLOBE NEWSWIRE) -- Advanced Back & Neck Care Center announced that the practice has welcomed two new doctors. Dr. Amy Cannatta is a Chiropractic Physician. Dr....
Chiropractor Announces Natural Pain Management for Headache Patients
June 24, 2012 10:00 ET
|
Peak Performance Chiropractic
GRAND RAPIDS, Mich., June 24, 2012 (GLOBE NEWSWIRE) -- Peak Performance Chiropractic in Grand Rapids, MI announced that the practice has had significant success using chiropractic care to help treat...